TFC News
Medication Standards
Why Medication Standards Must Reflect Real Patient Lives: the Thyroid Foundation’s Input to HSO’s CAN/HSO 3001:2025 September 2025 Last month, the Thyroid …
HSO Medication Management Public Review
The Health Standards Organization (HSO) is inviting public input on a draft national standard which will help shape how…
Bringing the Thyroid Patient Voice to Canada’s Drug Review Process
The Thyroid Foundation of Canada recently submitted formal feedback to Canada’s Drug Agency as part of a national
2025-2026 Board of Directors
The Thyroid Foundation of Canada is pleased to announce the 2025-2026 Board of Directors. The nominees were elected at the Annual General Meeting.
CDA Recommends Not to Reimburse Tepezza Drug
Canada’s Drug Agency (CDA) has issued its Draft Reimbursement Recommendation for Tepezza for Thyroid Eye Disease (TED)
No Iodine in Most Processed Foods
“Iodine deficiency appears to be on the rise across North America, say researchers.” “A 2022 study out of McMaster University in Hamilton …
